Conduit Pharmaceuticals Inc. (CDT) — Tangible Net Worth Ratio
Conduit Pharmaceuticals Inc. (CDT) has a Tangible Net Worth Ratio of 72.5% as of June 2026. This metric is calculated by deducting intangible assets ($380.94 Million) from net assets ($1.38 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore CDT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Conduit Pharmaceuticals Inc. Tangible Net Worth Ratio (2021–2025)
This chart shows how Conduit Pharmaceuticals Inc.'s Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 72.5%, reflecting net assets of $1.38 Billion with intangible assets of $380.94 Million USD. For live market cap and overall valuation, see CDT market cap.
Annual Tangible Net Worth Ratio for Conduit Pharmaceuticals Inc. (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Conduit Pharmaceuticals Inc. from 2021 to 2025, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore CDT capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.4% | $1.26 Billion | $399.80 Million | $3.54 Billion | ▼ -31.6 pp |
| 2021 | 100.0% | $20.62K | $0.00 | $213.12K | — |